Medical Affairs Study Manager - Oncology & Rare Tumors

The businesses of Merck KGaA, Darmstadt, Germany•Billerica, MA
•$137,000 - $206,800

About The Position

The Medical Affairs Study Manager leads operational delivery of evidence-generation studies across oncology and rare tumors, translating approved evidence priorities into executable study plans. The portfolio may include company-sponsored non-interventional studies, registries, and other real-world evidence initiatives. The role also coordinates company support for investigator-sponsored research, with responsibilities determined by sponsorship, applicable requirements, company procedures, and executed agreements. The manager works across Medical Affairs, Epidemiology/Real-World Evidence, Biostatistics, Data Management, Regulatory Affairs, Pharmacovigilance, Quality, Legal, Procurement, and external partners to deliver studies against approved timelines, budgets, and quality objectives. The work supports timely, transparent generation and dissemination of scientifically robust evidence addressing patient and clinical needs.

Requirements

  • Bachelor’s degree in life sciences, pharmacy, nursing, public health, or a related discipline, or an equivalent combination of relevant education and experience.
  • At least 7 years of relevant experience in pharmaceutical, biotechnology, CRO, academic research, or healthcare research settings, including demonstrated responsibility for study delivery.
  • Experience managing global or multicountry studies through planning, execution, and closeout.
  • Demonstrated experience managing CROs or other research vendors, study budgets, timelines, and operational risks.
  • Working knowledge of non-interventional studies, registries, or real-world evidence activities relevant to the assigned portfolio.
  • Understanding of applicable research ethics, data privacy, safety-reporting, and study-quality requirements.
  • Ability to influence cross-functional teams, communicate risks clearly, and resolve complex operational issues.

Nice To Haves

  • Advanced degree in a relevant scientific or health discipline.
  • Experience in oncology, rare tumors, or rare diseases.
  • Experience supporting investigator-sponsored research.
  • Experience with electronic health records, claims-based studies, disease registries, or other relevant real-world data sources.
  • Experience with study-management and document-management systems appropriate to the portfolio.
  • Experience supporting audits, inspections, or operational process improvement.

Responsibilities

  • Lead operational planning, startup, execution, and closeout of assigned company-sponsored studies, defining milestones, responsibilities, dependencies, and escalation pathways.
  • Develop and maintain integrated study plans, budgets, forecasts, risk assessments, and mitigation plans; communicate progress and material deviations to governance teams.
  • Coordinate country, site, investigator, and data-source feasibility with scientific and operational experts.
  • Lead or support CRO and vendor selection, contracting, onboarding, performance reviews, and issue resolution with Procurement and other functions.
  • Apply quality controls and oversight proportionate to study design, participant risk, data use, and applicable requirements; coordinate issue investigations and corrective actions with Quality and functional owners.
  • Coordinate ethics review, consent or waiver documentation, privacy reviews, and other applicable approvals with accountable functions.
  • Partner with Pharmacovigilance to establish and operationalize study-specific safety-information collection, exchange, and escalation processes.
  • Maintain complete, accurate, and appropriately archived study records in designated systems; support audits and inspections where applicable.
  • Coordinate protocol and analysis-plan documentation, study registration, results disclosure, and publication-related deliverables with accountable scientific and publication teams.
  • For investigator-sponsored research, coordinate internal review, agreements, funding milestones, status tracking, and company obligations while respecting investigator independence and sponsor responsibilities.
  • Address portfolio-specific feasibility challenges, including small or dispersed patient populations, data availability, site burden, and longitudinal follow-up.
  • Identify opportunities to improve study delivery, vendor performance, and operational consistency.

Benefits

  • Health insurance
  • Paid time off (PTO)
  • Retirement contributions
  • Other perquisites
  • Position may be eligible for sales or performance-based bonuses.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service